You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peginterferon alfa-2a

Showing 1 - 25 of 4,121
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (VIR-2218 and

Not yet recruiting
  • Chronic Hepatitis B
  • VIR-2218 and peginterferon alfa-2a
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 27, 2023

Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

Not yet recruiting
  • Membranous Nephropathy
  • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
  • Nice, France
    CHU de NICE
Jul 4, 2023

Acute Myeloid Leukemia Trial in Ann Arbor (peg-IFN-a, Hematopoietic Cell Transplant (HCT), Tacrolimus)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Oct 1, 2021

Chronic Viral Hepatitis B With Delta-agent Trial in Russian Federation (Myrcludex B, PEG IFN alfa-2a, Tenofovir)

Completed
Has Results
  • Chronic Viral Hepatitis B With Delta-agent
  • Myrcludex B
  • +2 more
  • Chelyabinsk, Russian Federation
  • +6 more
Apr 7, 2021

Hepatitis B, Chronic Trial in Worldwide (peginterferon alfa-2a [Pegasys])

Completed
Has Results
  • Hepatitis B, Chronic
  • peginterferon alfa-2a [Pegasys]
  • San Francisco, California
  • +38 more
Oct 26, 2022

Sars-CoV-2 Infection Trial in Baltimore (Peginterferon lambda alfa-1a subcutaneous injection, Saline)

Terminated
Has Results
  • Sars-CoV-2 Infection
  • Peginterferon lambda alfa-1a subcutaneous injection
  • Saline
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jul 12, 2022

Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

Recruiting
  • Chronic HBV Infection
  • Peginterferon alfa-2b combined and ETV
  • Shenzhen, China
    Shenzhen Third People Hospital
Mar 19, 2023

Multidisciplinary Support Program in Chronic Hepatitis C

Completed
Has Results
  • Hepatitis C, Chronic
  • Multidisciplinary support program
  • Barcelona, Spain
    Hospital del Mar
Sep 15, 2021

Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

Completed
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Aug 26, 2021

HIV, Hepatitis B, Hepatitis C Trial (Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin)

Withdrawn
  • HIV Infections
  • +2 more
  • Adefovir dipivoxil
  • +3 more
  • (no location specified)
Oct 28, 2021

Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

Recruiting
  • AIDS
  • Hepatitis B
  • Peginterferon alfa-2b Injection
  • Guangzhou, Guangdong, China
    Guangzhou Eighth People's Hospital, Guangzhou Medical University
Aug 10, 2023

Chronic Hepatitis Trial in Hangzhou, Shanghai (Group A, TDF, Group B:TDF then TDF and Peginterferon alfa-2a, Group C:TDF and

Recruiting
  • Chronic Hepatitis
  • Group A, TDF
  • +2 more
  • Hangzhou, China
  • +7 more
Sep 21, 2021

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

Chronic Hepatitis B Trial in China (Peginterferon alfa-2b injection, TDF)

Active, not recruiting
  • Chronic Hepatitis B
  • Peginterferon alfa-2b injection
  • TDF
  • Beijing, China
  • +32 more
Jul 17, 2022

Advanced Cholangiocarcinoma Trial in Washington (Pembrolizumab, Sylatron)

Terminated
Has Results
  • Advanced Cholangiocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Feb 14, 2022

Chronic Hepatitis B, High-Risk Cancer Trial in China (Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue, Nucleos(t)ide

Active, not recruiting
  • Chronic Hepatitis B
  • High-Risk Cancer
  • Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue
  • Nucleos(t)ide analogue
  • Chengdu, China
  • +8 more
Jan 4, 2023

Long-term Benefit in Chronic Hepatitis B Patients After Standard

Completed
  • Hepatitis B
  • Peginterferon Alfa-2B
  • Peginterferon Alfa-2A
  • Beijing, Beijing, China
  • +27 more
Apr 11, 2021

HIV, Hepatitis C Trial in United States (Ribavirin, Interferon alfa-2a, Peginterferon alfa-2a)

Completed
  • HIV Infections
  • Hepatitis C
  • San Diego, California
  • +23 more
Oct 28, 2021

HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

Completed
Has Results
  • HIV Infection
  • Hepatitis C Infection
  • Nitazoxanide (NTZ)
  • +2 more
  • Birmingham, Alabama
  • +17 more
Nov 2, 2021

Melanoma Trial in Pittsburgh (MK-3475, Peginterferon alfa-2b)

Completed
  • Melanoma
  • Pittsburgh, Pennsylvania
    Hillman Cancer Center
May 3, 2021

Chronic Hepatitis C Trial (Danoprevir, Ritonavir, peginterferon alfa-2a)

Completed
Has Results
  • Chronic Hepatitis C
  • (no location specified)
Feb 28, 2021

HIV, Hepatitis C Trial in United States (Ribavirin, Aldesleukin, Peginterferon alfa-2b)

Completed
  • HIV Infections
  • Hepatitis C
  • Los Angeles, California
  • +7 more
Oct 28, 2021

Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)

Active, not recruiting
Has Results
  • Malignant Melanoma
  • Peginterferon alfa-2b
  • +2 more
  • San Diego, California
  • +2 more
Apr 1, 2022

Hepatitis C, Chronic Trial (Boceprevir, Peginterferon alfa-2b (PEG2b), Ribavirin (RBV))

Completed
Has Results
  • Hepatitis C, Chronic
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Genotype 1 Trial (Boceprevir, Placebo, peginterferon alfa-2b)

Completed
Has Results
  • Chronic Hepatitis C Genotype 1
  • (no location specified)
Jan 15, 2021